Hofseth International AS ("HI"), a close associate of Hofseth Biocare ASA's (the
"Company") board member Roger Hofseth, has notified the Company that HI has made
the following purchases of shares in the Company.

On 11 May 2022, HI purchased 24,000 shares in the Company at an average price of
approximately NOK 3,89 for a total subscription amount of NOK 93,434.4.

On  29 December 2022, HI  purchased 53,572 shares  in the  Company at an average
price  of  approximately  NOK  2,80 for  a  total  subscription  amount  of  NOK
150,429.44.

On  30 December 2022, HI purchased  178,215 shares in the  Company at an average
price  of  approximately  NOK  3,36 for  a  total  subscription  amount  of  NOK
599,530.72.

Please see the attached notification forms for further information.
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This  information is subject to the  disclosure requirements in the Market Abuse
Regulation  EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.